Fig. 1From: Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching ‘liquid biopsy’ and quantitative tumor modelingResearch protocol workflow. * If receiving induction chemotherapy, first sample of blood collected pre-chemotherapyBack to article page